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Motivational Interviewing with computer
assistance as an intervention to empower women
to make contraceptive choices while incarcerated:
study protocol for randomized controlled trial
Jennifer Clarke1,2*, Melanie A Gold3, Rachel E Simon1,2, Mary B Roberts1,2 and LAR Stein4
Abstract
Background: Unplanned pregnancies and sexually transmitted infections (STIs) are important and costly public
health problems in the United States resulting from unprotected sexual intercourse. Risk factors for unplanned
pregnancies and STIs (poverty, low educational attainment, homelessness, substance abuse, lack of health insurance,
history of an abusive environment, and practice of commercial sex work) are especially high among women with a
history of incarceration. Project CARE (Contraceptive Awareness and Reproductive Education) is designed to
evaluate an innovative intervention, Motivational Interviewing with Computer Assistance (MICA), aimed at
enhancing contraceptive initiation and maintenance among incarcerated women who do not want a pregnancy
within the next year and who are anticipated to be released back to the community. This study aims to: (1)
increase the initiation of highly effective contraceptives while incarcerated; (2) increase the continuation of highly
effective contraceptive use at 3, 6, 9, and 12 months after release; and (3) decrease unsafe sexual activity.
Methods/Design: This randomized controlled trial will recruit 400 women from the Rhode Island Department of
Corrections (RI DOC) women’s jail at risk for an unplanned pregnancy (that is, sexually active with men and not
planning/wanting to become pregnant in the next year). They will be randomized to two interventions: a control
group who receive two educational videos (on contraception, STIs, and pre-conception counseling) or a treatment
group who receive two sessions of personalized MICA. MICA is based on the principles of the Transtheoretical
Model (TTM) and on Motivational Interviewing (MI), an empirically supported counseling technique designed to
enhance readiness to change targeted behaviors. Women will be followed at 3, 6, 9, and 12 months post release
and assessed for STIs, pregnancy, and reported condom use.
Discussion: Results from this study are expected to enhance our understanding of the efficacy of MICA to enhance
contraceptive initiation and maintenance and reduce sexual risk-taking behaviors among incarcerated women who
have re-entered the community.
Trial registration: NCT01132950
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Background
Almost half of all pregnancies in the United States are
unplanned, a higher percentage than in several other
industrialized countries [1,2]. Seventy percent of women
between 18 and 29 years of age are at risk of unplanned
pregnancy [3], a higher proportion than any other age
group [4]. The social and financial costs of unplanned
pregnancies are staggering. In 2006, 64% of births in the
Unites States resulting from unintended pregnancies
were publicly funded, compared with 48% of all births
and 35% of births resulting from intended pregnancies.
Of the 2 million publicly funded births, 51% resulted
from unintended pregnancies, accounting for $11.1 bil-
lion in costs [5]. Unplanned pregnancies have been asso-
ciated with negative antenatal behaviors and birth
outcomes [6-10].
Sexually transmitted infections (STIs) are some of the
most commonly reported diseases in the United States
with approximately 19 million cases occurring annually
[11]. STIs can cause serious and even life-threatening se-
quelae including cancer, ectopic pregnancy, infertility,
chronic pelvic pain, spontaneous abortion, stillbirth, low
birth weight, prematurity, congenital and perinatal infec-
tions, neurological damage, and death. More recent data
indicate that many STIs increase the risk of HIV trans-
mission at least three- to five-fold [12]. The economic
cost of STIs is staggering. Women, minority populations,
and adolescents are disproportionately affected by STIs.
The incidence of STIs and their sequelae are consistently
higher among African Americans and Hispanic Ameri-
cans than among Caucasians [11]. In addition, two-
thirds of all STIs occur in people younger than 25 years
of age [13].
Previous research indicates that both unplanned pregnan-
cies and STIs disproportionately affect poor and medically
underserved women, especially the incarcerated population
[14]. Among incarcerated women, risk factors for
unplanned pregnancies are very high (low educational at-
tainment, poverty, homelessness, and substance abuse) [15]
and over 80% of incarcerated women at risk for an un-
planned pregnancy report a history of an unplanned preg-
nancy. Many women with incarceration histories lose
custody of their children either because of substance abuse,
lack of resources, or re-incarceration. Approximately half of
women in prison and jail are between the ages of 18 and
34 years. Over three-quarters of women in jail at risk for an
unplanned pregnancy report they want to start a contracep-
tive method [16]. Furthermore, national statistics of STIs
among incarcerated women reveal rates of chlamydia and
gonorrhea at 7.2% and 1.6%, respectively [17]. STI rates
vary by state but are 12 to 16 times higher in prisons and
jails than in the general population [17].
Women comprise approximately 3.2 million arrests an-
nually and many pass through prisons and jails. With so
many women at high risk for unplanned pregnancies and
STIs passing through United States jails annually, improv-
ing contraceptive service utilization and STI prevention
services in this non-traditional setting has the potential to
reach the women in the greatest need of services. We will
conduct a randomized controlled trial (RCT) of an in-
novative intervention based on motivational interviewing
aimed at enhancing contraceptive initiation and mainten-
ance among incarcerated women who do not want a preg-
nancy within the next year and who are anticipated to be
released back to the community.
Motivational Interviewing (MI) to decrease unplanned
pregnancies and STIs
MI provides an empirically supported style for matching
counseling to an individual’s readiness to change. Based
on the principles of motivational psychology, client-
centered therapy, and the Transtheoretical Model (TTM),
[18,19] MI represents a general and practical approach for
facilitating behavior change by enhancing and eliciting a
client’s own internal motivation for change.[20] Responsi-
bility for changing a behavior is assumed to lie within the
individual, and ambivalence is recognized as a natural part
of this change process. MI is designed to assist clients in
working through ambivalence and in moving toward
change. Their ambivalence may reflect a desire for a preg-
nancy in which case the MI counselor changes focus to
having a healthy pregnancy. Utilizing MI techniques, the
counselor helps the participant identify barriers to using
birth control and methods for overcoming those barriers.
MI targets increasing interest and confidence in accessing
and using condoms and other forms of birth control and
use of family planning professionals. Elements of the
protocol are tailored to a woman’s specific needs including
holding off on pregnancy until she is ready (for example,
is financially stable or has a steady partner); it focuses on
good and not-so-good ways regarding how to effectively
negotiate use of contraceptives with partners (not so good
would be to carry a knife to dissuade aggressive partners),
decreasing use of alcohol and other drugs during sex
(which may make it harder to use birth control and con-
doms), increasing use of referrals to family planning
clinics, and identifying barriers specific to women and
generating possible solutions. The MI counselor utilizes
techniques including providing personalized feedback, re-
flective listening, exploring pros and cons of change, giv-
ing affirmations, supporting client autonomy and self-
efficacy, eliciting ‘self-motivational statements’ (problem
recognition, intention to change, optimism about change),
and generating solutions to potential barriers to change.
Of critical importance, MI emphasizes client’s personal
choice regarding change, de-emphasizes labeling the client
and her behaviors, and avoids arguing with or confronting
the client with the need to change.
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Published studies include successful MI interventions
with individuals who smoke tobacco [21], those who are
addicted to heroin on methadone [22], psychiatric inpati-
ents with and without co-morbid substance use disorders
[23], and obese women with non-insulin dependent dia-
betes [24]. MI is especially effective with individuals who
are ‘resistant’ [25], ‘angry’ [26], or not ready to change be-
cause the therapeutic process includes recognition and
resolution of ambivalence about change. Brief interven-
tions using MI have been postulated to be particularly
well-suited to incarcerated populations [27], because of
their brief duration, non-confrontational, and empathic
therapist style, emphasis on facilitating the individual’s
consideration of the effects of their behavior on other life
areas, and allowance for multiple options for change.
There are currently few published studies evaluating the
use of brief interventions to alter overall contraceptive be-
havior. Belcher and colleagues evaluated the effectiveness
of a motivational skill-based intervention to decrease sex-
ual risk behavior in adult women as compared to a stand-
ard educational intervention [28]. Women randomized to
MI reported significantly higher rates of condom use and
had significantly fewer reports of unprotected intercourse
as compared to controls. Reported condom use for
women in the MI group rose from 22% to 66% as com-
pared to an increase of 27% to only 43% among controls
at 3 months post-intervention (P <0.02).
A Centers for Disease Control study entitled ‘Project
CHOICES’ evaluated the impact and acceptability of a
four-session MI intervention (n=190) designed to reduce
alcohol-exposed pregnancies among high-risk women by
targeting both contraception use and drinking [29].
Among women who completed the 6-month follow-up,
68.5% were no longer at risk of having an alcohol-exposed
pregnancy; 12.6% reduced drinking alone; 23.1% used ef-
fective contraception alone; and 32.9% reported both
behaviors.
A total of three RCTs assess the impact of MI on
women’s contraceptive behaviors in the context of redu-
cing alcohol-exposed pregnancy (AEP). Ingersoll et al.
reported their preliminary findings from a RCT of a
single-session MI-based intervention to reduce AEP risk
among college women (18 to 24 years) [30]. Significantly
fewer women in the control group (48%) reported using
effective contraception at 1-month follow-up as com-
pared to those in the MI group (64%), P <0.03. Signifi-
cantly more participants in the MI group (74%) were no
longer at risk for AEP at 1 month compared to control
participants (54%), P <0.005. This study demonstrated
the potential of MI to alter contraceptive risk-taking
behaviors among young women in college.
Peterson et al. conducted a RCT of a two-session MI-
based intervention to reduce the risk of unintended preg-
nancy and STIs among women aged 16 to 44 years [31].
No significant differences were found between the interven-
tion and control groups between baseline and 12 months.
They concluded that additional MI sessions may be neces-
sary to improve contraceptive decision-making and to re-
duce the risk of unintended pregnancies and STIs [31].
Barnet et al. investigated the effectiveness of a computer-
assisted motivational intervention in preventing rapid sub-
sequent birth to adolescent mothers. They randomly
assigned participants (pregnant teenagers, aged 18 years
and older who were at more than 24 weeks’ gestation) into
three groups. The first group received a multicomponent
home-based intervention, the second received a single-
component home-based intervention, and the third
received usual standard perinatal care. Results indicated
that completion of two of more computer-assisted motiv-
ational intervention sessions, either alone or within a multi-
component home-based intervention, reduced the risk of
rapid subsequent birth [32]. A review of theory-based inter-
ventions for contraception further supports MI as an inter-
vention to prevent STIs [33].
These studies point to the potential effectiveness of an
MI intervention to increase contraceptive use, reduce
unintended pregnancies, and decrease STI incidence.
We are the first to conduct a RCT using the MI inter-
vention to alter contraceptive behaviors among incarcer-
ated women, to assess its impact on contraceptive use
other than condoms, and to separate pregnancy from
STI prevention. Project CARE (Contraceptive Awareness
and Reproductive Education) is designed to evaluate
an innovative intervention, Motivational Interviewing
with Computer Assistance (MICA), aimed at enhancing
contraceptive initiation and maintenance among incar-
cerated women who do not want a pregnancy within the
next year and who are anticipated to be released back to
the community.
Methods/Design
Study objectives
The present study is designed to enhance our understand-
ing of the efficacy of MICA to improve contraceptive use
and safer sexual activity for incarcerated women.
The primary objectives are to: (1) increase the initi-
ation of highly effective contraceptives while incarcer-
ated; (2) increase the continuation of highly effective
contraceptive use at 3, 6, 9, and 12 months; and decrease
unsafe sexual activity.
Participants
Participants will be recruited from the Rhode Island De-
partment of Corrections (RI DOC) women’s division. All
women between the ages of 18 and 35 years will be
approached by a research assistant for study participa-
tion and after obtaining verbal consent will be screened
for eligibility. This screening visit and all subsequent
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visits occur in a private location and study participation
is not discussed with security staff.
Inclusion criteria include: (1) 18 to 35 years of age; (2)
currently sexually active with men defined as having
vaginal-penile intercourse at least monthly in the past three
non-institutionalized months; (3) answered ‘No’ to ‘Do you
plan to become pregnant within the next 12 months?’ (4)
expected place of residence after release in Providence
County or within 15 miles of follow-up site; (5) willing to
comply with protocol, follow-up, and provide at least one
locator; and (6) fluent in English.
Exclusion criteria include: (1) inability to give informed
consent secondary to organic brain dysfunction, not
having own legal guardianship, or active psychosis or
otherwise unable to participate in the intervention or
assessments (deaf, blind, or impaired communication skills
that impair ability to participate in computerize assess-
ment or counseling); (2) pregnant or trying to become
pregnant within the next year; (3) hysterectomy, bilateral
oophorectomy, tubal sterilization (by ligation or coils),
intrauterine device (IUD), implantable contraceptive
devices (Implanon) or other procedures which make it ex-
tremely unlikely to become pregnant; (4) women who are
monogamous for more than 1 year with a partner who has
had a vasectomy; (5) housed in segregation as we would
be unable to recruit them for the study (once released
from segregation a woman would then become eligible).
Setting
This RCT was conducted at the RI DOC women’s facil-
ity, a state-run correctional system. It is a combined
prison and jail housing both awaiting trial and sentenced
individuals. It functions mostly as a jail with few women
sentenced to more than 1 year. The average daily popu-
lation is 240. Because many women are incarcerated
more than once in a year the number of individual
women who enter the RI DOC is less than 2,180, and
the median length of stay is 3 days. The majority of
women are White (51%), however African American
(30.8%) and Hispanics (17.6%) are over-represented
(state population 5.7% and 12.4%, respectively) [34].
Over 80% are under 40 years old.
Procedures/Interventions
A research assistant (RA) will recruit potential partici-
pants in the housing units at the RI DOC. She will iden-
tify herself as non-RI DOC staff and inform women that
study participation is completely voluntary and will not
affect any privileges at the facility. Individuals who are
interested in participating will be given an informed con-
sent form to review and the study will be explained.
Given that incarcerated populations are vulnerable
populations with limited rights, the informed consent
process is particularly important. The RA will detail that
study participation is not linked to any extra medical or
non-medical services in prison and will not influence
parole status or any other jail privileges. Additionally, it
will be explained that she does not need to participate in
the study to receive reproductive health services. It will
be explained that this is a confidential study but that if
there is any information that a participant may harm
herself, another person, or that a child or an elderly or
disabled individual is in danger then that information
will be reported. If there is a threat made to the security
of the prison then prison staff will be informed. Counse-
lors are instructed not to discuss study participation
with any one at the RI DOC. All study staff are certified
through the hospital in Human Subjects Protection and
HIPAA, and a certificate of confidentiality has been
obtained to further insure participant confidentiality.
Inclusion and exclusion criteria will be reviewed. If eli-
gible and willing to participate in the study, the informed
consent process will be completed (study explained, con-
sent form read to the individual, and questions answered)
and forms signed. Locator information will be obtained
and consents signed for tracking [35].
Participants will be randomized by age (25 years or
younger vs. older than 25 years), race/ethnicity (non-His-
panic White vs. other), and pregnancy intentions (wants
no more pregnancies vs. wants a future pregnancy). Future
pregnancy plans will be assessed by a single question: ‘Do
you want to have any/anymore children?’ Based on these
criteria there will be eight randomization groups. A ran-
dom number generator will determine intervention status
for the eight groups. Intervention status is then placed
into sequentially numbered envelopes for the eight groups
and each envelope is sealed and opened in order as
women become eligible in each of the eight groups.
Before the first intervention session, a 45-60-minute
computer-assisted questionnaire will be administered to
the participant. From the baseline questionnaire, we will
gather the following information: demographics, obstet-
ric and gynecologic history, length of stay in prison,
medical insurance, primary care provider or clinic, rela-
tionship violence, childhood abuse, addiction, and de-
pression. These measures will aid in assessing the complex
context in which a woman ‘chooses’ to initiate or not initi-
ate contraceptive services.
The counselor/RA will then administer MICA or
video according to randomization. Self-obtained vaginal
samples for Trichomoniasis vaginalis, C. trachomatis,
and N. gonorrhoeae will be obtained as well as a urine
sample for a pregnancy test. Contraceptive, sexual, and
drug-related risk behaviors will be measured via a calen-
dar recall behavioral assessment, a Timeline Followback
(TLFB) calendar of the prior 90 days at baseline and at
each follow-up visit [36,37]. This assessment utilizes a
calendar-based recall method using anchor dates to
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facilitate a more accurate response set. It also allows for
a more thorough assessment of risk behaviors by allow-
ing for the analysis of risk patterns by sexual partner,
drug, and alcohol use and the co-occurrence of sexual-
and drug-related risk, all within the context of life
events. A detailed assessment of sexual behaviors and
condom use with each of the participant’s other sex part-
ners will be made by the participant.
MICA
Participants randomized to MICA will receive all core MI
elements in the MICA sessions. A key component of any
MI-based intervention is for the counselor to support au-
tonomy by explicitly stating that it is the participant, not
the counselor, who will make decisions regarding behavior
change. Counselors will lead the participant in a directed,
empathic discussion that includes a review of the Timeline
Followback (TLFB) calendar, pregnancy intentions, the
pregnancy and STI risk assessment printouts, and Stages
of Readiness to Change. The behaviors targeted vary de-
pending on the needs of the participant with the overall
goal of decreasing the risk for unplanned pregnancies and
STIs. For example, some want to focus on decreasing the
number of sex partners, some using birth control consist-
ently, and others want to see a medical provider to initiate
a birth control method. The counselor will support the
participant’s decision to make, or consider the possibility
of, change. All MICA participants will receive: (1) feedback
on personal risks for pregnancy and STIs; (2) clear advice
to avoid pregnancy (until it is desired) and STIs that might
impact future fertility by either using highly effective con-
traceptives and condoms consistently and correctly or
staying abstinent; and (3) a review of the menu of options
by which to prevent pregnancy and STIs. Detailed educa-
tion about contraceptive choices is offered according to
the participant’s needs and requests. The session will end
with the development of a ‘CARE plan’ in which the par-
ticipant lists her goals and methods for reaching her STI
and pregnancy prevention goals. A second MICA session
will be conducted 3 months after release and include a re-
view of the’CARE plan’ as well as elements provided in
session one. If a woman chooses no method or decides
she wants to become pregnant then preconception coun-
seling is offered.
VIDEO
Participants randomized to control videos will watch in-
formation on contraception and STI prevention that a
participant would need to avoid exposure to intercourse
that is poorly protected against pregnancy and against
STIs. The baseline video is about contraception and is
matched in time to the MICA sessions. At the 3-month
post release session the video focuses on STIs, condom
use, and preconception counseling.
At the end of the MICA or video session, the counselor
will offer participants a list of community-based locations
at which contraceptive services and STI screening can be
accessed inexpensively or for free. Each participant will
also be offered a referral to the Title X reproductive health
educator at the jail. (In conjunction with RI DOC, the
Title X program provides reproductive health services in
jail and then transitional services in the community after
release.) On-site contraceptive options include oral
contraceptive pills, contraceptive patches, vaginal rings,
and medroxyprogesterone injections. The counselor will
suggest that the participant visit her primary care provider,
the prison physician or one of the sites on the list for
contraceptive supplies, annual pelvic examinations, and
regular STI screening.
Follow-ups will occur at 3, 6, 9, and 12 months post re-
lease in the community or prison if re-incarcerated. This is
a challenging population to track and retain in a longitu-
dinal study. However, we have refined methods for tracking
participants as they re-enter the community. In our
previous trials, including Project WISE (PI Clarke
R01DA024093), we have been able to locate and retain over
80% of participants for their follow-up assessments. Partici-
pants are asked to sign a letter for all locators that explains
that they are participating in a research study and gives
their permission to provide the study staff with information
about the participant’s whereabouts if needed. Prior to each
follow-up assessment, study staff attempt to contact partici-
pants to remind them of the appointment by letters and
phone calls. The participant is asked to review and confirm
or edit contact information at each visit. Financial compen-
sation for the time and effort to provide assessment infor-
mation and biologic samples also aids in study retention.
Questionnaire measures include contraceptive use, bar-
riers to family planning services, relationship violence,
substance use, depressive symptoms, pregnancy intentions
and plans [20], sexual assertiveness, relationship status,
and housing situation. In addition, participant biological
outcomes will be assessed at each visit and include a self-
obtained vaginal samples for Trichomoniasis vaginalis,
C. trachomatis, and N. gonorrhoeae as well as a urine sam-
ple for a pregnancy test.
Primary hypotheses and outcomes
1. MICA will increase the initiation of highly effective
contraceptives in jail more than educational videos.
The primary outcome is initiation of a highly
effective contraceptive method prior to release from
jail. This will be measured by a review of the
medical records and documentation of participants
having received a contraceptive injection, pills,
patch, ring, or other contraceptive device. Type of
contraceptive and amount given will be recorded.
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2. Women randomized to MICA will be more likely to
continue the use of highly effective contraception at
3, 6, 9, and 12 months compared to women
randomized to educational videos. The primary
outcome is continued highly effective contraceptive
use at 3, 6, 9, and 12 months. This will be measured
through the TLFB calendars and confirmed with a
review of the medical records. The secondary
outcome is pregnancy as documented by a urine
pregnancy test at each follow-up visit.
3. MICA will more effectively decrease unsafe sexual
behavior more than educational videos. The primary
outcome is an incident STI after a negative baseline
test. The secondary outcome is intercourse that is
poorly protected against STIs at 3, 6, 9, and
12 months as determined by the TLFB.
Sample size
The sample size calculation is based on the biological
outcomes and is the most conservative estimate. Data
from our prior work (project CONNECT [20]) shows
that the 6-month incidence of an STI was 33% [38]. We
assume over a 12-month period this will increase to
43%. From this data, we assume that the intervention
will decrease the incidence a moderate amount to 31%.
Similarly, we assume a type I error of α= 0.05, an aver-
age within-subject correlation of 0.50 and a conservative
estimate of a 20% attrition rate [39]. Using the similar
procedure as above, the proposed enrollment of 400 par-
ticipants (200 participants for each intervention) at
baseline will achieve power of 80% to detect assumed dif-
ferences after considering four repeated measures (3, 6, 9,
and 12 months). Our proposed sample size may provide
greater power to detect interaction effects, robustness to
violations of model assumptions, protection against mul-
tiple comparison error rates, and increased efficiency to
detect weaker relationships between variables.
Statistical analyses
Primary analyses
Data analyses will be performed using the Statistical
Analysis System, SAS 9.1.3 (SAS Institute, Inc, Cary,
NC, USA). Following intention-to-treat principles, all
participants who have been randomized to the two inter-
ventions will be included in the analyses. All significance
tests will be two-tailed.
Contraceptive initiation (Aim #1)
Analyses of contraceptive initiation while incarcerated will
include the percentage of participants starting a highly ef-
fective method requiring infrequent user maintenance
(Subdermal implant, injectable contraception, or an IUD)
as well as highly effective methods requiring more regular
non-coital use (contraceptive pills, vaginal rings, and the
patch). Initiation of contraception use (yes/no) will be ana-
lyzed using logistic regression to determine if women ran-
domized to the MICA condition are more likely to initiate
a contraceptive method while incarcerated than women
randomized to the video condition. Baseline randomization
characteristics (for example, age, race/ethnicity, and preg-
nancy intentions) will be incorporated in the initial model
to insure randomization was successfully accomplished.
Odds ratios and their 95% confidence intervals will be
calculated for MICA using the video condition as the
referent.
Contraceptive continuation (Aim #2)
Analyses of contraceptive continuation will include the
assessment of highly effective contraception use (yes/no)
at the four follow-up time points. In addition to assess-
ment of contraception use, pregnancy intentions will
also be assessed at each time point. Generalized linear
mixed models (GLMM) will be used to analyze the bin-
ary outcome. GLMM allows for flexibility in the distri-
bution of the outcome and can also incorporate repeated
measures of both dependent and independent variables.
Independent variables in the GLMM will include treat-
ment group, pregnancy intentions, an indicator variable
for time as well as risk factors for unplanned/unwanted
pregnancy (education, health insurance status, alcohol/
drug use, and pregnancy history). Testing the interaction
between treatment group and time will inform us whether
differences in contraceptive outcomes between treatment
conditions become more or less pronounced over the 12-
month follow-up.
Incident STIs (Aim #3)
Analyses of incident STIs will evaluate all STIs tested
throughout the study. GLMM will be used, and we will
follow the similar procedure outlined in Aim #2.
Secondary analyses
STI and pregnancy risk behaviors
For this analysis we will utilize the TLFB data to identify
the percentage of at-risk days that women engage in sex-
ual activity not protected against an unplanned preg-
nancy. We will include use of all coital and non-coital
contraceptive methods in this analysis, as well as sexual
activity without a condom (not protected against STIs).
GLMM will be used to test this hypothesis, and we will
follow the similar procedure outlined in Aim #2.
Predictors of contraceptive use
Predictive variables will include demographics of age,
race/ethnicity, and education as well as drug and alcohol
use, depression, recent and childhood victimization, and
pregnancy history. Following the stages of change, deci-
sional balance, process of change, and self-efficacy will
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allow for an in-depth evaluation of the intervention. By
following changes in these processes, the components of
the intervention which most affect behavioral change
can be determined.
Alternatively, we will also use measurement modeling
to incorporate multiple measures, such as the self-
reported primary outcomes and the incidence of preg-
nancy and STI in a latent factor that captures variance
common to all measures [40]. Statistical analyses with
latent variables allow us to minimize measurement error
and thereby increase validity of the study.
Treatment fidelity
To promote treatment integrity, all treatment sessions
will be audio-recorded and reviewed weekly by the treat-
ment supervisor, who will use a MICA adherence check-
list to assess session content and process as well as the
MITI 3.1.1 scale to assess the quality of MI at each ses-
sion [41,42]. Prior to enrolling participants, counselors
will receive individualized feedback and coaching by a
treatment supervisor who has reviewed every audio-
recorded MICA sessions until the counselors are certi-
fied to competently conduct MICA counseling. Then
counselors will receive feedback and coaching for the
first 10 audio-recorded MICA sessions and over time
will be provided with written feedback and coaching for
every other to every third audio recordings. To insure fi-
delity an independent reviewer will code 10% of all
coded MICA sessions using the Motivational Integrity
Treatment Integrity scale. A counselor who falls below
acceptable levels of proficiency in MICA will be identi-
fied and re-trained until able to demonstrate the neces-
sary knowledge and skills.
Discussion
The United States female jail population is a large popu-
lation, particularly among women of childbearing age.
Women leaving jail are at high risk for unplanned preg-
nancies and STIs and face many barriers to reproductive
health services such as lack of insurance, transportation
issues, and child care issues [43-47]. This research pro-
ject is a RCT of an experimental intervention for incar-
cerated women at risk for unplanned pregnancies and
STIs. It will compare changes in the initiation and main-
tenance of highly effective contraceptives and STI risk
behaviors at multiple time points up to 12 months after
release from the incarcerated setting. Improving contra-
ceptive service utilization in this non-traditional setting
has the potential to reach the women in the greatest
need of services.
Trial status
Recruitment for this trial is ongoing and expected to
end by September 2012.
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